These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38278268)

  • 1. Epidemic-specific association of maternal exposure to per- and polyfluoroalkyl substances (PFAS) and their components with maternal glucose metabolism: A cross-sectional analysis in a birth cohort from Hong Kong.
    Yang A; Tam CHT; Wong KK; Ozaki R; Lowe WL; Metzger BE; Chow E; Tam WH; Wong CKC; Ma RCW
    Sci Total Environ; 2024 Mar; 917():170220. PubMed ID: 38278268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to per- and polyfluoroalkyl substances as a risk factor for gestational diabetes mellitus through interference with glucose homeostasis.
    Xu C; Zhang L; Zhou Q; Ding J; Yin S; Shang X; Tian Y
    Sci Total Environ; 2022 Sep; 838(Pt 4):156561. PubMed ID: 35691348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study.
    Zang L; Liu X; Xie X; Zhou X; Pan Y; Dai J
    Environ Pollut; 2023 Jun; 326():121504. PubMed ID: 36965679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between maternal exposure to per- and polyfluoroalkyl substances and serum markers of liver function during pregnancy in China: A mixture-based approach.
    Liao Q; Tang P; Fan H; Song Y; Liang J; Huang H; Pan D; Mo M; LeiLei ; Lin M; Chen J; Wei H; Long J; Shao Y; Zeng X; Liu S; Huang D; Qiu X
    Environ Pollut; 2023 Apr; 323():121348. PubMed ID: 36842621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of perfluoroalkyl and polyfluoroalkyl substances with gestational hypertension and blood pressure during pregnancy: A cohort study.
    Yang L; Ji H; Liang H; Yuan W; Song X; Li X; Niu J; Shi H; Wen S; Miao M
    Environ Res; 2022 Dec; 215(Pt 2):114284. PubMed ID: 36088993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of per- and polyfluoroalkyl substances (PFAS) and their mixture with oxidative stress biomarkers during pregnancy.
    Taibl KR; Schantz S; Aung MT; Padula A; Geiger S; Smith S; Park JS; Milne GL; Robinson JF; Woodruff TJ; Morello-Frosch R; Eick SM
    Environ Int; 2022 Nov; 169():107541. PubMed ID: 36191484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Per- and Polyfluoroalkyl Substances (PFAS) With Glucose Tolerance During Pregnancy in Project Viva.
    Preston EV; Rifas-Shiman SL; Hivert MF; Zota AR; Sagiv SK; Calafat AM; Oken E; James-Todd T
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2864-76. PubMed ID: 32480407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to Per- and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China.
    Sun S; Xie Z; Song X; Wen S; Yuan W; Miao M; Ji H; Liang H
    Ecotoxicol Environ Saf; 2024 Jan; 269():115751. PubMed ID: 38042132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
    Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.
    Preston EV; Hivert MF; Fleisch AF; Calafat AM; Sagiv SK; Perng W; Rifas-Shiman SL; Chavarro JE; Oken E; Zota AR; James-Todd T
    Environ Int; 2022 Jul; 165():107335. PubMed ID: 35696844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFAS concentrations in early and mid-pregnancy and risk of gestational diabetes mellitus in a nested case-control study within the ethnically and racially diverse PETALS cohort.
    Peterson AK; Zhu Y; Fuller S; Feng J; Alexeeff S; Mitro SD; Kannan K; Robinson M; Padula A; Ferrara A
    BMC Pregnancy Childbirth; 2023 Sep; 23(1):657. PubMed ID: 37704943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus.
    Zhang Y; Chen R; Gao Y; Qu J; Wang Z; Zhao M; Bai X; Jin H
    Environ Pollut; 2023 Jan; 317():120833. PubMed ID: 36493933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of legacy perfluoroalkyl and polyfluoroalkyl substances, alternatives, and isomers with gestational diabetes mellitus and glucose homeostasis among women conceiving through assisted reproduction in Shanghai, China.
    Mao D; Ding G; Wang Z; Zhao J; Li H; Lei X; Zheng J; Zhang Y; Shi R; Yuan T; Liu Z; Gao Y; Tian Y
    Environ Sci Pollut Res Int; 2024 Feb; 31(9):14088-14102. PubMed ID: 38273080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
    Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
    Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study.
    Buckley JP; Kuiper JR; Lanphear BP; Calafat AM; Cecil KM; Chen A; Xu Y; Yolton K; Kalkwarf HJ; Braun JM
    Environ Health Perspect; 2021 Sep; 129(9):97011. PubMed ID: 34585601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental exposure to legacy and emerging per- and polyfluoroalkyl substances and endometriosis in women of childbearing age.
    Ao J; Zhang R; Huo X; Zhu W; Zhang J
    Sci Total Environ; 2024 Jan; 907():167838. PubMed ID: 37839491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.